Specializing in targeted anti-cancer drugs, Nanjing Ange Pharmaceutical Co. engages in the research, development and manufacturing of APIs and intermediates. Since establishing our company in 2003, we have been focusing on anti-cancer drugs such as Ceritinib, Lenvatinib, Afatinib and others. We have become a top supplier in this category with one of the most complete product offerings. Having exported to 7 different countries, we constantly strive to perfect our product quality while lowering costs.